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ABSTRACT 
 
Objective: The objective of this selective EBM review is to determine whether or not 
hypnotherapy is an effective treatment in smoking cessation in comparison to alternative 
methods? 
 
Study Design: Systematic review of 3 English language primary studies, published between 
2013-2014. 
 
Data Sources: Three randomized controlled trials (RCTs) published on/after 2013 comparing 
the use of hypnotherapy to alternative methods in the treatment of smoking cessation. The other 
methods include nicotine replacement therapy, relaxation therapy and single versus group 
hypnotherapy and were obtained using the Cochrane Library and PubMed.   
 
Outcomes Measured: The outcome of each study measured the effects of hypnotherapy by self-
reported smoking abstinence and counting the number of cigarettes smoked per day at various 
follow up intervals. 
 
Results: Dickson-Spillman and co-authors showed there was no significant difference in 
reported abstinence rates at the 2-week follow up (p=0.13) and the 6-month follow up (p= 0.73). 
In addition to the 2 week follow up, there was no significant difference between the mean 
number of cigarettes smoked in the past 7 days when comparing hypnotherapy to relaxation 
therapy (p = 0.69). Hasan and co-authors demonstrated patients receiving hypnotherapy versus 
nicotine replacement therapy were more likely to remain abstinent at 12 and 26 weeks post 
hospitalization, although there was no significant difference (p= 0.14 and 0.06, respectively). 
Riegel found at the end of treatment, group therapy reported a 48.2% quit rate whereas 
individual therapy reported a 37.9% quit rate with a 95% CI [0.61,3.80]. At the 3 month follow 
up, GT reported a 19.6% quit rate whereas IT reported a 13.8% quit rate with a 95% CI 
[0.44,5.30]. There were minimal to no adverse side effects reported in all three studies. 
 
Conclusion: Hypnotherapy does appear to aid in smoking cessation; however, based on the 
findings in the three studies addressed in this review, there is not a statistically significant 
difference when using hypnotherapy to treat smoking cessation compared with alternative 
methods. The use of hypnosis to treat smoking cessation along with its treatment for other 
psychotherapies and addictions will likely be further explored in the future. 
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INTRODUCTION 
Cigarette smoking is the leading cause of preventable disease and death in the United 
States, attributing to 1 in 5 deaths annually.1 It is estimated that 17.8% of U.S. adults aged 18 
years or older currently smoke cigarettes. 2 Regardless of why people begin smoking tobacco, it 
is found that smokers have a greater risk of developing lung cancer, stroke and heart disease 
when compared to non-smokers.2 Other illnesses that have direct associations with smoking 
tobacco include but are not limited to: Chronic Obstructive Pulmonary Disease (COPD), cancers 
of the larynx and mouth, esophageal cancer, pancreatic cancer, bladder cancer, cervical cancer, 
acute myeloid leukemia, colon cancer, asthma attacks and Crohn’s disease. Those that partake 
are more at risk for cataracts, type 2 diabetes mellitus and rheumatoid arthritis. Interestingly 
enough, it can even have an effect on fertility and increase the risk for birth defects, miscarriages 
and stillbirths. 2   
Not only are the ill effects of smoking an expense to the individual monetarily and health 
wise, smoking is also a huge cost in medicine. In the U.S. the total economic cost of smoking is 
more than $300 billion annually, which includes $170 billion in direct medical care and $156 
billion in lost productivity due to its adverse effects. 1, 3 There is not an exact estimate of the 
number of health care visits each year currently available; however, “smoking contributes $67 
billion in expenditures for hospitals, $21 billion in ambulatory care, $10.6 billion in nursing 
home care, $25.5 billion in prescription drugs, and $8.2 billion in other services”. 1 
The proven risks associated with smoking tobacco clearly outweigh the benefits, which is 
why teaching non-smokers about abstinence and current smoking about cessation is of the 
utmost importance. Smoking cessation is the process of discontinuing tobacco use. After 
cessation has begun, some risks associated can be reduced shortly after. For example, 1 year after 
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cessation the risk of a myocardial infarction drops significantly and after 10 years, the risk for 
lung cancer drops by half. 2 
The process of smoking cessation can prove a challenge for patients and become 
frustrating after multiple attempts without success. The reason that is so incredibly difficult for 
some to refrain from smoking cigarettes after use is in part due to the chemicals contained in a 
cigarette. Tobacco contains a mixture of chemicals and additives including nicotine, an addictive 
chemical that aids in the process of dependence, tolerance and withdrawal symptoms. Nicotine 
was found to be the most addictive drug in the United States. 4 Nicotine prevents the reuptake of 
acetylcholine ultimately increasing the amount in the central nervous system and skeletal muscle 
junctions. This in turn triggers a chemical reaction, which increases heart rate, alertness and 
reaction time. When inhaled and absorbed through the alveoli in the lungs, nicotine is directly 
associated with cardiovascular disease and causes a multitude of other disease processes. 
Simultaneously as this is occurring, dopamine and endorphins are released which are 
neurotransmitters that play a critical role in reward-motivated behavior and ultimately add to the 
pleasure associated with smoking. 2 
There are numerous treatment options that play a critical role in smoking cessation. 
Currently used methods for treatment are but not limited to quitting abruptly without assistance 
which is also known as “cold turkey”, nicotine replacement therapies (patch, gum, lozenge, 
inhaler, nasal spray), prescription dosed nicotine replacement therapy, anti-depressant 
medications (Varenicline tartrate, Bupropion SR), laser therapy, acupuncture, hypnotherapy, 
counseling and support groups. 2 A combination of these modalities may be used such as therapy 
with medication or two or more therapies together. However, as with all types of therapies and 
medications, each method will work differently depending upon the individual patient.   
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OBJECTIVE 
The objective of this selective EBM review is to determine whether or not “Is hypnotherapy 
an effective treatment in smoking cessation in comparison to alternative methods?” 
METHODS 
The criteria used for the selection of the 3 studies included both men and women over the 
age of 18 currently using inhaled tobacco. The intervention being reviewed in this study included 
hypnotherapy sessions. In one study, hypnotherapy was compared to nicotine replacement 
therapy. In another RCT, hypnotherapy was compared to group relaxation therapy. Lastly, 
hypnotherapy was compared between group and single sessions. The outcomes measured in the 3 
studies included the incidence of self-reported smoking cessation and counting the number of 
cigarettes smoked per day. The types of studies included are 3 randomized controlled trials 
(RCTs); one is a free choice study and another a cluster randomized, parallel-group, controlled 
trial.  
Key words used to search the articles included “hypnotherapy” and “smoking cessation”. 
All articles were originally published in peer-reviewed journals in the English language. Data 
was searched and collected by the author using articles in PubMed and the Cochrane library from 
2013-2014. Articles were selected based on relevance to the clinical question and if they 
included patient oriented evidence that matters (POEMS). Inclusion criteria consisted of studies 
that were RCTs or clinical trials published after 2012, additional criteria in Table 1. Exclusion 
criteria included patients under 18 years old. The statistics of this study used to evaluate patient 
outcomes included p values, RBI, NBI, CI, and NNT. The demographics and characteristics of 
the included studies are displayed in table 1. 
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Table 1 - Demographics & Characteristics of included studies (Table 1) 
Study Type #Pts Age 
(yrs) 
Inclusion 
Criteria 
Exclusion 
Criteria 
W/D Interventions 
Dickson-
Spillmann5 
(2013) 
Cluster
-RCT 
223 18 
years 
and 
older 
-Consuming 
greater than or 
equal to 5 
cigarettes/day 
-Willing to quit 
-Not using 
cessation aids 
at the time 
-Acute alcohol 
or substance 
abuse 
-Signs of 
psychotic 
symptoms 
noticed by 
therapist at start 
of session 
37 Hypnotherapy 
vs. Relaxation 
therapy 
Hasan6 
(2014) 
RCT 122 18- 
75 
years 
old 
-Current 
smokers 
admitted with a 
cardiac or 
pulmonary 
illness 
 
-Patients 
admitted with a 
terminal illness  
-Pregnant 
-History of 
substance abuse 
or a major 
psychiatric d/o 
-If they could 
not be followed 
after discharge 
due to cognitive 
or language 
barriers 
-Those that 
have received 
hypnotherapy or 
NRT in the past 
6 months 
 
42 Hypnotherapy 
vs. Nicotine 
Replacement 
Therapy  
Riegel7 
(2013) 
RCT; 
free 
choice 
study 
85 23 – 
68 
years 
old 
-Smoking 
history of at 
least 2 years 
- Daily 
consumption 
of at least 10 
cigarettes/day 
-Under 23 years 
old 
8 Group vs. 
Individual 
hypnotherapy 
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OUTCOMES MEASURED 
 All of the outcomes measured were POEMS related to the treatment of smoking 
cessation. In the study by Dickson- Spillmann and co-authors, the outcomes measured were by 
counting the number of cigarettes. This was accomplished by counting the number of cigarettes 
smoked per day at a 2-week follow up and at a 6-month follow up. 5 
 In the study by Hansan, Zagarins and co-authors the outcomes were measured by self 
reported smoking abstinence. This was recorded at a 12 week and 26 week post- hospitalizations 
follow up. 6 
In the study by Riegel the outcomes were measured using a symptom checklist – 90- 
revised (SCL – 90 R), creative imagination scale (CIS) and questionnaire on changes in 
experience and behavior called Veranderungsfragebogen des Erlebens end Verhaltens (VEV). 
This was recorded with quit rates at the end of treatment and again at a 3 month follow up with a 
tolerance interval of 2 weeks. 7 
RESULTS 
 Three studies compared the use of hypnotherapy to treat smoking cessation in adults age 
18 years and older currently smoking inhaled tobacco. One study was a randomized controlled 
trial6, one was a cluster randomized, parallel-group, controlled trial5 and one was a randomized 
controlled trial: a free choice study. 7 
 Dickson-Spillman and co-authors conducted a study containing 223 smokers that were 18 
years or older. During recruitment, they noticed the pattern of “clusters” of individuals that 
shared similar features (such as work colleagues) therefore this trial falls under a cluster-
randomized, parallel group, controlled trial. Participants needed to be consuming greater than or 
equal to 5 cigarettes per day, willing to quit and not using any type of cessation aid at the time. 
Participants were excluded from the study for alcohol and/or substance abuse, and signs of 
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psychotic symptoms noticed by a therapist at the start of sessions. There was no upper limit on 
age. After viewing advertisements, participants were mailed information about the interventions, 
cost, associated risks and how randomization worked. The therapy sessions consisted of three 
parts: a psycho-educational part (40 minutes), the actual intervention (40 minutes), and a 
debriefing about which intervention was given (20 minutes).  The 37 participants that withdrew 
were considered “continuing smokers”. At the 2-week follow up, there was no significant 
difference in reported abstinence rates when comparing hypnotherapy to relaxation therapy 
(p=0.13). In addition, there was no significant difference between the mean number of cigarettes 
smoked in the past 7 days when comparing both interventions (p = 0.69). At the 6-month follow 
up, the intervention was not significant on self-reported 30-day nicotine abstinence (p= 0.73). 
The NNT was calculated to be -2.1% (see Table 2), so this negative number means for every 2 
participants who were treated with a single session of group hypnotherapy there was one fewer 
incidence of smoking cessation than in the group of participants in the single group relaxation 
therapy. There were no adverse events found. 5	  
Table 2. Analysis of Outcomes and Numbers Needed to Treat. 
Dickson(2013) Patients CER EER RBI ABI NNT 
 223 17.8% 14.7% -0.17% -3.1% -2.1% 
 
Hasan and co-authors studied 164 current smokers between the ages of 18 and 75 years 
old admitted with a pulmonary or cardiac illness. Participants were excluded if they had a history 
of substance abuse, psychiatric illness, terminal illness, pregnant, unable to follow up due to a 
behavioral or language barrier and/or if they have received NRT or hypnotherapy within the last 
6 months. Participants were randomized to 1 of 3 treatments: hypnotherapy, NRT or a 
combination or the two. Hypnotherapy consisted of one, ninety-minute session, 1-2 weeks post-
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hospitalization by a certified hypnotist and tobacco treatment specialist. Those in the NRT group 
received a free one-month supply of patches with the dose based on the amount and time they 
smoked prior to hospitalization.  Of the initial sample size, 42 participants declined treatment and 
were included in a separate “self quit” group. Patients receiving hypnotherapy were more likely 
to remain abstinent at 12 and 26 weeks post hospitalization compared to those receiving NRT. 
Although there is no significant difference (p= 0.14), 43.9% of patients receiving hypnotherapy 
remained abstinent compared with 28.2% receiving NRT at 12 weeks. At 26 weeks, smoking 
abstinence rates were 36.6% with hypnotherapy and 18% with NRT, showing no significant 
difference (p= 0.06). NNT was calculated to be 6, which is moderately small for this study (see 
table 3). This study reports no adverse effects of the interventions found. 6	  
Table 3. Analysis of Outcomes and Numbers Needed to Treat. 
Hasan(2013) Patients CER EER RBI ABI NNT 
 164 18% 36.6% 103% 18.6% 5.37% 
 
 Riegel studied 93 smokers between the ages of 23 and 68 years old. Inclusion criteria 
included at least a 2-year smoking history with use of at least 10 cigarettes per day. In this free 
choice study, patients were given the option of individual versus group hypnotherapy sessions. 
Eight patients declined consent and were excluded from this study, leaving a total of 85 patients 
in the final sample. Individual treatment (IT) consisted of 29 people and 3 sessions of therapy 
whereas group treatment (GT) consisted of 56 people that participated in 4 sessions; each session 
was 90 minutes long. At the end of treatment, GT reported a 48.2% quit rate whereas IT reported 
a 37.9% quit rate with a 95% CI [0.61,3.80]. At the 3 month follow up, GT reported a 19.6% quit 
rate whereas IT reported a 13.8% quit rate with a 95% CI [0.44,5.30]. NNT was calculated to be 
10, which is very small for this study (see table 4). Drop out rates were 23.5% during treatment 
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and 34.1% missing at follow-up, which was due to stress, illness, unsatisfactory treatment and 
abstinence before treatment began; they were counted for as smokers. The data collected 
suggests the majority of subjects did not feel side effects of the treatment. 7	  
Table 4. Analysis of Outcomes and Numbers Needed to Treat.	  
Riegel (2013) Patients CER EER RBI ABI NNT 
 85 37.9% 48.2% 27% 10.3% 9.7% 
 
DISCUSSION 
 Smoking cessation is a common problem many patients and practitioners are faced with. 
It poses a challenge to stop a routine once formed as a habit, especially while withdrawal 
symptoms can occur, such as: weight gain, cravings, feeling irritable and having trouble 
thinking. 8,9 There are various methods for cessation such as nicotine replacement therapy and 
prescription medications, however one study estimated that 22% of smokers relapsed within 3 
months. 10 Data has demonstrated that over 42% of all adults that use cigarettes on a daily basis 
stopped smoking for one day or more in 2012 because they were trying to quit.1 
Hypnotherapy is an alternative method used in smoking cessation that does appear to aid 
in abstinence 5,6,7. This method of psychotherapy gives the patient an opportunity to change 
certain behaviors by using guided relaxation, increased concentration and focused attention 
allowing the therapist to work on specific tasks while blocking out distractions simultaneously. It 
is important to note while in this trance like state the patient has full control over their mind and 
body. 11 
Hypnosis has also been implemented in other settings which includes but is not limited 
to: treating specific phobias, pain management, anxiety, headaches, pre-operation settings, 
depression, asthma, eating disorders and utilized in labor and delivery. The risks associated with 
this therapy include creating false memories unintentionally created by the therapist, which is 
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why hypnosis remains controversial for treating dissociative disorders. Other side effects 
include: drowsiness, headache, anxiety and/or stress, however none of these adverse side effects 
were reported in the three studies being analyzed. 5,6,7,11 
 One problem with the proposed treatment is insurance coverage. Due to the fact that 
hypnosis is considered an alternative medicine intervention currently undergoing 
experimentation and investigation, many insurance companies will not cover the therapy. 
Insurance companies such as Aetna indicate that there is inadequate evidence of peer-reviewed 
medical literature for the effectiveness of hypnosis. 12 It is likely due to the unknown benefit of 
the therapy that insurance companies wont cover the cost and maintenance thereafter, making 
this an expense to the patient and risk they have to be willing to take.  
There are limitations that exist when collecting evidence regarding hypnosis used in the 
treatment of smoking cessation. All 3 studies shared some similar limitations restricting their 
efficacy. Due to the nature of the studies, it was impossible to keep the participants blinded with 
an intervention of hypnotherapy. This could have lead to a motivational incentive to remain 
abstinent for those receiving the therapy intervention. Also, there was no control group in all 
three studies giving no definitive baseline for comparison. In addition, each of the studies had a 
relatively small sample size, which poses difficulty in applying these results to a larger sample of 
demographics. 5,6,7 Furthermore, each study should remain ongoing to demonstrate whether 
continued abstinence is obtained. Additional studies warrant a larger sample size and ongoing 
follow-ups for an extended period of time to collaborate statistics on the extended effects of 
hypnotherapy. 
 There were also specific limitations to the study by Dickson-Spillman and co-authors. 
The inclusion criteria did not include a specific time frame needed for patients to use cigarettes 
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to qualify for the study. Participants joined in “clusters” of social networks and work-place 
colleagues, allowing motivation to become negatively or positively affected by those around 
them. Also, there was a drop out rate of 37 participants that were considered “continued 
smokers” which could have skewed the results. 5 
The Hasan and co-authors study was conducted post-hospitalization allowing pulmonary 
and cardiac illness to dictate the population size and whether patients were able to follow up. 
Roughly 1/3 of patients withdrew from the study and were placed in a “self quit” group, 
decreasing the initial sample size and skewing results of the study. This was the only study in 
this review to have placed the use of nicotine replacement therapy or hypnotherapy in the past 6 
months in their exclusion criteria, allowing researchers to visualize the benefits of the therapy 
without intervening influences. 6  
In the Riegel study, it demonstrates the issue with an initial small sample size and 
applying the data to the rest of the population. Also, with the exception of age there were no 
exclusion criteria for the population making it difficult to generalize the results to similar patient 
demographics. 7 
CONCLUSION 
Hypnotherapy does appear to aid in smoking cessation; however, based on the findings in 
the three studies addressed in this review, there is not a statistically significant difference when 
using hypnotherapy to treat smoking cessation compared with alternative methods 5,6,7. Studying 
tobacco smokers is difficult for both the participant and the researcher due to the high rate of 
relapse in this population, ability to keep participants blinded, sample size and associated co-
morbidities among this population. 1,5,6,7  
 Future research studies should consider placing patients in a controlled setting. For 
example, an inpatient treatment center would limit the external stressors for relapse during trials. 
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A comparison of abstinence rates between those in the treatment center versus those in a home 
environment pre-treatment and post-treatment would be useful. This would be similar to how 
other substance abuse is treated in partial hospitalization and inpatient centers, especially if there 
are multiple substance abuse diagnoses occurring at the same time. Research could also 
demonstrate craving scales and checklists while in the treatment center. In future studies stricter 
inclusion criteria should be set for the amount and time of consumption of cigarettes and the 
willingness of the participant to quit. Exclusion criteria should include co-morbidities posing 
threat to the study and withdrawal rates. Further studies are also needed to aim for FDA and 
insurance approval. The use of hypnosis to treat smoking cessation along with its treatment for 
other psychotherapies and addictions will likely be further explored in the future. 
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